Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET.

Pfisterer M, Brunner-La Rocca HP, Rickenbacher P, Hunziker P, Mueller C, Nietlispach F, Leibundgut G, Bader F, Kaiser C; BASKET.

Eur Heart J. 2009 Jan;30(1):16-24. doi: 10.1093/eurheartj/ehn516. Epub 2008 Nov 25.

PMID:
19033260
2.

Coronary stent healing, endothelialisation and the role of co-medication.

van Beusekom HM, Schoemaker R, Roks AJ, Zijlstra F, van der Giessen WJ.

Neth Heart J. 2007;15(11):395-6. No abstract available.

3.

High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents.

Polyak B, Fishbein I, Chorny M, Alferiev I, Williams D, Yellen B, Friedman G, Levy RJ.

Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):698-703. doi: 10.1073/pnas.0708338105. Epub 2008 Jan 8.

4.

Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years.

Zähringer M, Sapoval M, Pattynama PM, Rabbia C, Vignali C, Maleux G, Boyer L, Szczerbo-Trojanowska M, Jaschke W, Hafsahl G, Downes M, Bérégi JP, Veeger NJ, Stoll HP, Talen A.

J Endovasc Ther. 2007 Aug;14(4):460-8.

PMID:
17696619
5.

Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.

Vassileva V, Grant J, De Souza R, Allen C, Piquette-Miller M.

Cancer Chemother Pharmacol. 2007 Nov;60(6):907-14. Epub 2007 Mar 21.

PMID:
17375303
6.

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L; SCAAR Study Group.

N Engl J Med. 2007 Mar 8;356(10):1009-19. Epub 2007 Feb 12.

7.

Determination of paclitaxel in human and rat blood samples after administration of low dose paclitaxel by HPLC-UV detection.

Yonemoto H, Ogino S, Nakashima MN, Wada M, Nakashima K.

Biomed Chromatogr. 2007 Mar;21(3):310-7.

PMID:
17221932
8.

Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.

Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaff MR, Mudde C, Tielemans H, Beregi JP.

J Endovasc Ther. 2006 Dec;13(6):701-10.

PMID:
17154704
9.

Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.

Fishbein I, Alferiev IS, Nyanguile O, Gaster R, Vohs JM, Wong GS, Felderman H, Chen IW, Choi H, Wilensky RL, Levy RJ.

Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):159-64. Epub 2005 Dec 21.

10.

Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial.

Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Mudde C, Tielemans H, Bérégi JP.

J Vasc Interv Radiol. 2005 Mar;16(3):331-8.

PMID:
15758128
11.

Early experiences and clinical implications of drug-eluting stents: part 1.

Chong PH, Cheng JW.

Ann Pharmacother. 2004 Apr;38(4):661-9. Epub 2004 Feb 6. Review.

PMID:
14766994
12.

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.

Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME; TAXUS II Study Group.

Circulation. 2003 Aug 19;108(7):788-94. Epub 2003 Aug 4.

13.

Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods.

Chorny M, Fishbein I, Danenberg HD, Golomb G.

J Control Release. 2002 Oct 30;83(3):401-14.

PMID:
12387948
14.

In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.

Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Wan Kim S, Seo MH.

J Control Release. 2001 May 14;72(1-3):191-202.

PMID:
11389998
15.

Solid-state characterization of paclitaxel.

Liggins RT, Hunter WL, Burt HM.

J Pharm Sci. 1997 Dec;86(12):1458-63.

PMID:
9423162
16.

Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.

Verrecchia T, Huve P, Bazile D, Veillard M, Spenlehauer G, Couvreur P.

J Biomed Mater Res. 1993 Aug;27(8):1019-28.

PMID:
8408114
17.

An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen.

Moghimi SM, Hedeman H, Muir IS, Illum L, Davis SS.

Biochim Biophys Acta. 1993 Jul 11;1157(3):233-40.

PMID:
8323953
18.

Serum albumin.

Peters T Jr.

Adv Protein Chem. 1985;37:161-245. Review. No abstract available.

PMID:
3904348
19.

Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating.

Moghimi SM, Porter CJ, Muir IS, Illum L, Davis SS.

Biochem Biophys Res Commun. 1991 Jun 14;177(2):861-6.

PMID:
2049107
20.

Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats.

Bazile DV, Ropert C, Huve P, Verrecchia T, Marlard M, Frydman A, Veillard M, Spenlehauer G.

Biomaterials. 1992;13(15):1093-102.

PMID:
1493193

Supplemental Content

Support Center